NEJM Evidence Issues Research Articles in April 2023 Edition
March 29, 2023
March 29, 2023
WALTHAM, Massachusetts, March 29 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its April 2023 edition:
Original Articles:
* Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma
* Adaptive Strategies for Retention in Care among Persons Living with HIV
* Osmotic . . .
Original Articles:
* Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma
* Adaptive Strategies for Retention in Care among Persons Living with HIV
* Osmotic . . .